1. Home
  2. CAE vs ALKS Comparison

CAE vs ALKS Comparison

Compare CAE & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

HOLD

Current Price

$25.18

Market Cap

8.2B

Sector

N/A

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$52.78

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAE
ALKS
Founded
1947
1987
Country
Canada
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.7B
IPO Year
2002
2012

Fundamental Metrics

Financial Performance
Metric
CAE
ALKS
Price
$25.18
$52.78
Analyst Decision
Buy
Buy
Analyst Count
3
14
Target Price
$33.33
$43.43
AVG Volume (30 Days)
522.2K
1.8M
Earning Date
05-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,475,899,000.00
Revenue This Year
$4.97
$24.26
Revenue Next Year
N/A
$4.47
P/E Ratio
$35.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.76
$25.17
52 Week High
$34.24
$55.67

Technical Indicators

Market Signals
Indicator
CAE
ALKS
Relative Strength Index (RSI) 50.12 59.36
Support Level $24.77 $50.49
Resistance Level $26.18 $55.67
Average True Range (ATR) 0.62 1.58
MACD -0.03 -0.50
Stochastic Oscillator 41.50 40.40

Price Performance

Historical Comparison
CAE
ALKS

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: i) Civil Aviation: Provides comprehensive training solutions for flight, cabin, maintenance, ground personnel and air traffic controllers in commercial, business and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training and crew sourcing services, as well as airline operations digital solutions; and ii) Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: